Type 1 since age 16, diagnosed during her time with the Swedish National Tennis Team which sparked her lifelong career fighting autoimmune diseases.
Kidney and pancreas transplant survivor.
Karin Hehenberger is a physician, investor, diabetes expert, and founder of Lyfebulb, a patient empowerment platform which improves improves the lives of those impacted by chronic disease.
Prior to Lyfebulb, Karin consulted on healthcare and diabetes projects at McKinsey & Company, was a senior executive at hedge funds and a venture capital firm, led metabolic disease strategy for Johnson & Johnson, and served as SVP of Strategic Alliances at the Juvenile Diabetes Research Foundation (JDRF).
Three-time cancer survivor, global cancer advocate.
Doug Ulman is President and CEO of Pelotonia, the largest single-event cycling fundraiser in the US based on ridership, which has raised more than $61 million for cancer research in its first five years.
Prior to Pelotonia, Doug was President and CEO of the The LIVESTRONG Foundation, growing it from a small local charity into a $500 million global brand, and was President of the Lance Armstrong Foundation.
Type 1 diabetes since 1999.
Mark Heyman is a licensed Clinical Psychologist with expertise in the emotional and behavioral aspects of diabetes, including changes that improve physical and mental health outcomes in people with diabetes.
As Founder and Director of the Center for Diabetes and Mental Health, Mark trains healthcare providers on the psychosocial, emotional and behavioral aspects of diabetes.
When Mark was diagnosed with diabetes in 1999, he was frustrated by the lack of resources available to help people navigate living with diabetes.
Now as a diabetes psychologist, Mark provides education and evidence-based clinical treatment to people with diabetes, trains health care providers, and provides consulting services to the diabetes business community.
Oded Kraft is VP Products at Kornit Digital.
Prior to Kornit, Oded led product teams at Medingo, a medical devices company that created semi-disposable insulin patch pumps, and Roche Diabetes Care (Germany).
Oded joined Medingo in 2008 after working for seven years at GE Healthcare Nuclear Medicine division in a Global Segment Leader position, and before that, as a System Architect.
Dr. David Rodbard is President of Biomedical Informatics Consultants, based in Washington DC, and is a specialist in diabetes and clinical endocrinology.
David’s published research focuses on diabetes management and self-care, including clinician decision-support systems, diabetes analysis and insights, and self-monitoring of blood glucose data.
Prior to consulting, David spent 30 years as a Principal Investigator for the National Institutes of Health.
One Drop for Android Coming Soon